Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tamoxifen: an emerging preventive.

Frontiers in bioscience : a journal and virtual library - 1 Sept 2004

Schwartz Jan

Abstract excerpt

Tamoxifen is well known for its actions as an antagonist of estrogen receptor-mediated signaling and is one of the most extensively used endocrine agents both in the clinic and in the research setting. Tamoxifen has emerged from recent Breast Cancer Prevention Trials, conducted to evaluate risk reduction, as an effective preventive agent. Specifically, comparing tamoxifen to placebo (for 5 years) has shown that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticarcinogenic Agents
Share to Antineoplastic Agents, Hormonal
Share to Estrogen Receptor alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor beta

Share to Estrogens

Share to Menopause

Share to Selective Estrogen Receptor Modulators

Share to Tamoxifen

Source

Identifiers

PMID: 15353318
DOI: 10.2741/1440

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tamoxifen: an emerging preventive.PMID 15353318Read ↗

From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters.Semantic proximity Read ↗

Chemoprevention of breast cancer for women at high risk.Semantic proximity Read ↗

A mechanism of drug resistance to tamoxifen in breast cancer.Semantic proximity Read ↗

A molecular model for the mechanism of acquired tamoxifen resistance in breast cancerSemantic proximity Read ↗

Prevention of breast cancer.Semantic proximity Read ↗

[Breast cancer prevention: from chemoprevention to prophylactic surgery].Semantic proximity Read ↗

Breast cancer prevention: present and future.Semantic proximity Read ↗

[Molecular aspects of different mechanisms of tamoxifen resistance].Semantic proximity Read ↗

Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial.Semantic proximity Read ↗

Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.Semantic proximity Read ↗

Should you be taking tamoxifen?Semantic proximity Read ↗

Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.